Eribulin and Confusion: A Previously Unknown Drug Side-Effect
KeywordsEribulin, encephalopathy, breast cancer
Eribulin is an antineoplastic agent used in advanced breast cancer refractory to anthracycline and taxane treatment regimens. A wide variety of side effects with unclear mechanisms have been noted, but encephalopathy has not been widely reported. Here we describe the case of a middle-aged woman treated with eribulin for advanced breast cancer who subsequently developed central nervous system drug-induced toxicity but improved promptly with steroid administration.
Issue: Vol 7 No 9 (view)